European Medicines Agency must take account of cardiovascular harm associated with degludec insulin

Thomas A. Schmidt, Clifford J. Rosen, John S. Yudkin

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

Adgang til dokumentet

@article{0e93e715590e4cb6bbbf84eda0e8d238,

title = "European Medicines Agency must take account of cardiovascular harm associated with degludec insulin",

author = "Schmidt, \{Thomas A.\} and Rosen, \{Clifford J.\} and Yudkin, \{John S.\}",

year = "2013",

month = jun,

day = "20",

doi = "10.1136/bmj.f3731",

language = "English",

volume = "346",

journal = "BMJ (Online)",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

number = "7912",

}

TY - JOUR

T1 - European Medicines Agency must take account of cardiovascular harm associated with degludec insulin

AU - Schmidt, Thomas A.

AU - Rosen, Clifford J.

AU - Yudkin, John S.

PY - 2013/6/20

Y1 - 2013/6/20

UR - https://www.scopus.com/pages/publications/84879201353

U2 - 10.1136/bmj.f3731

DO - 10.1136/bmj.f3731

M3 - Letter

C2 - 23757746

AN - SCOPUS:84879201353

SN - 0959-8146

VL - 346

JO - BMJ (Online)

JF - BMJ (Online)

IS - 7912

M1 - f3731

ER -